Regulatory updates, compliance insights, and industry analysis from the ACPL team.
CPCB has moved from rule-making to enforcement on plastic EPR—Registered Environment Auditors, customs blocks, and crore-level penalties are now live.…
Read MoreRegulatory compliance has always been the backbone of a trustworthy supply chain, but a recent directive from the Central Drugs…
Read More
CDSCO Bans 16 Fixed Dose Combinations: What Pharma Companies Need to Know Effective June 11, 2026, the Central Drugs Standard…
Read More
CDSCO Issues Final Guidance on Medical Device Software under MDR 2017: What Manufacturers Need to Know
Read MoreDPIIT's June 2026 footwear QCO amendments extend the legacy stock sell-off deadline to July 31, 2027 and ease R&D import…
Read MoreFSSAI's March 2026 licensing overhaul and milk-sector advisory bring perpetual licences, new turnover slabs, and high-risk inspections for dairy. Here's…
Read MoreIndia's June 2026 narcotics enforcement surge and the DCC-approved real-time tracking portal raise the bar for pharmaceutical supply chain compliance.
Read More
Materiovigilance Services in India: Safeguarding Medical Device Safety and Performance India’s medical device industry is expanding fast, but that growth…
Read MoreA new controlled substance under NDPS was notified in March 2026 with stock and registration deadlines in July–August 2026. Here's…
Read More